The Temple Health CME Program

The Temple Health CME Program embraces evidence-based programs which promote new concepts in patient safety and enhance excellence in care.


WELCOME

The Temple Health CME Program’s purpose is to support the educational needs of the medical staffs of the Fox Chase Cancer Center (the American Oncologic Hospital and the Institute for Cancer Research) and Jeanes Hospital’s integrated campus in order to improve patient care.

The CME Program embraces evidence-based programs which promote new concepts in patient safety and enhance excellence in care. We strive to improve patient outcomes through an interdisciplinary approach to patient-centered care which strengthens interpersonal communication between healthcare providers, patients and families.

The Temple Health CME Program is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Temple Health CME offers onsite programs including grand rounds, case conferences, tumor boards, morbidity and mortality meetings, Schwartz Center Rounds™, and enduring materials. The wide-campus educational offerings include online lectures as well as regional symposiums.

PROGRAM HIGHLIGHTS

Non-Small Cell Lung Carcinoma with EGFR Mutations
The Past, Present and Future of EGFR-Targeted Therapies and Beyond
March 1, 2019
8:30 am - 9 am Registration & Breakfast 
9 am - 3:15 pm CME-Certified Program 

Presented by Fox Chase Cancer Center and The Temple Health Office for Continuing Medical Education, this program is designed to provide physicians with an overview of EGFR mutations in lung cancer and the associated biology, treatment options and future directions in the field.

Join speakers from Fox Chase Cancer Center, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Penn Medicine's Abramson Cancer Center, Vanderbilt University Medical Center and Yale Cancer Center as they present information on EGFR-mutant lung cancer and current therapies, the mechanisms of acquired resistance to approved therapies, and new therapeutic options.

Learn more